New Sight Saving Technology - Heidelberg Retina Tomograph (HRT) .
Glaucoma is the leading cause of irreversible vision loss in the United States - affecting about three million Americans. Unfortunately, up to 50% of people are unaware that they have the disease. Glaucoma develops without warning. Too often, treatment isn't sought until a degree of vision has deteriorated. At that point, steps may be taken to control the progression of the disease, however the vision that is noticeably impaired is lost forever.
The key to preventing vision loss is early glaucoma detection. Dr. Svetlana Tsipursky with Advanced Eye Care, Ltd. recently acquired the Heidelberg Retina Tomograph II (HRT II) to provide state of the art and forefront technology to fight this blinding disease - often before vision suffers.
The HRT II is a confocal scanning laser ophthalmoscope. It not only detects the very early stages of glaucoma, but also provides eye doctors with essential information for monitoring the disease in follow-up exams. By scanning the optic nerve and adjacent nerve fiber layer, the HRT II produces a three dimensional topographic map. It generates extremely accurate, detailed data and comprehensive analysis that simply is not possible to obtain with traditional examinations.
The HRT II exam is fast, safe, and usually does not require dilating the eye. While a patient sits comfortably in a stationary position, a laser scans the eye for just a few seconds (at a lower energy level than that produced from a television remote control).
Glaucoma can develop in anyone. However, some people are considered at higher risk than others - including individuals over age 60, African-Americans over age 40, and people with high blood pressure, diabetes, or a family history of glaucoma.
Advanced Eye Care is among a few practices in Chicago-land to offer the comprehensive, non-invasive HRT II exam for early diagnostic and monitoring of glaucoma. If you, or someone you know, are at high risk for glaucoma, ask your optometrist or ophthalmologist about a referral to Dr. Svetlana Tsipursky for an HRT II exam.
|
New Glaucoma Treatment - Selective Laser Trabeculoplasty (SLT). |
||||
Doctor Tsipursky is now happy to offer
her patients the latest innovation in glaucoma treatment - Selective Laser
Trabeculoplasty (SLT). This procedure uses short pulse, low
energy "cool" laser. The applications are placed directly on trabecular
meshwork (the draining channels that do not function adequately in
glaucoma), affect only pigmented cells stimulating the channels without
burning them. SLT is very effective in lowering the eye pressure thus
preventing permanent vision loss. In many cases SLT may be as or more effective than glaucoma drops.
This is painless, in office procedure associated with no systemic side effects.
SLT therapy is reimbursed by Medicare and most other insurance providers.
